Hambalek Helga, Matuz Mária, Ruzsa Roxána, Papfalvi Erika, Nacsa Róbert, Engi Zsófia, Csatordai Márta, Soós Gyöngyvér, Hajdú Edit, Csupor Dezső, Benkő Ria
Institute of Clinical Pharmacy, Faculty of Pharmacy, University of Szeged, 6725 Szeged, Hungary.
University Pharmacy Department, Albert Szent-Györgyi Health Center, University of Szeged, 6725 Szeged, Hungary.
Antibiotics (Basel). 2024 Sep 5;13(9):848. doi: 10.3390/antibiotics13090848.
The COVID-19 pandemic affected the epidemiology of infectious diseases and changed the operation of health care systems and health care seeking behavior. Our study aimed to analyze the utilization of systemic antibiotics in ambulatory care in Hungary after the COVID-19 pandemic and compare it to the period before COVID. We defined three periods (24 months each): Before COVID, COVID, and After COVID. Monthly trends in systemic antibiotic (J01) use were calculated using the WHO ATC-DDD index and expressed as DDD/1000 inhabitants/day (DID) and number of exposed patients per active agent. The data were further categorized by the WHO AWaRe classification. In the After COVID period, we detected almost the same (11.61 vs. 11.11 DID) mean monthly use of systemic antibiotics in ambulatory care compared to the Before COVID period. We observed a decrease in the seasonality index in the After COVID period (46.86% vs. 39.86%). In the After COVID period, the use of cephalosporins and quinolones decreased significantly, while in the case of macrolides, a significant increase was observed compared to the Before COVID period, with excessive azithromycin use (66,869 vs. 97,367 exposed patients). This study demonstrated significant changes in the pattern of ambulatory care antibiotic use in Hungary.
新冠疫情影响了传染病的流行病学,改变了医疗保健系统的运作以及人们寻求医疗保健的行为。我们的研究旨在分析新冠疫情后匈牙利门诊医疗中全身用抗生素的使用情况,并将其与新冠疫情前的时期进行比较。我们定义了三个时期(每个时期24个月):新冠疫情前、新冠疫情期间和新冠疫情后。使用世界卫生组织的解剖学治疗学化学分类系统-限定日剂量指数计算全身用抗生素(J01)的月度使用趋势,并表示为每1000居民每日限定日剂量数(DID)以及每种活性药物的暴露患者数量。数据进一步按照世界卫生组织的药物应用的解剖学、治疗学和化学分类系统(AWaRe)分类。在新冠疫情后时期,我们发现与新冠疫情前时期相比,门诊医疗中全身用抗生素的月均使用量几乎相同(分别为11.61和11.11 DID)。我们观察到新冠疫情后时期的季节性指数有所下降(从46.86%降至39.86%)。在新冠疫情后时期,头孢菌素和喹诺酮类药物的使用显著减少,而大环内酯类药物的使用与新冠疫情前时期相比显著增加,阿奇霉素使用过量(暴露患者分别为66,869例和97,367例)。这项研究表明匈牙利门诊医疗抗生素使用模式发生了显著变化。